Siena Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Siena Capital's PFE Position: Q3 2022 in Review
Siena Capital reduced its Pfizer (PFE) stake by 96% in Q3 2022, selling an estimated $14.6K and leaving 14 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #146.
Siena Capital first reported a position in PFE in Q1 2022 and has held it in 3 quarters since. The position peaked at $20K in Q1 2022. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Siena Capital held 14 shares of Pfizer worth $1K as of Q3 2022.
- Siena Capital sold 300 Pfizer shares in Q3 2022, an estimated $14.6K.
- Pfizer made up ﹤0.01% of Siena Capital's portfolio in Q3 2022, its #146 holding.
- Siena Capital first reported a position in Pfizer in Q1 2022 and has held it in 3 quarters since.
- Siena Capital's Pfizer position peaked at $20K in Q1 2022.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Siena Capital's 13F filing for Q3 2022, filed 2 Nov 2022.